Carolina Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.71M Sell
13,010
-57
-0.4% -$19.5K 1.85% 13
2026
Q1
$4.6M Buy
13,067
+11,989
+1,112% +$4.27M 1.91% 11
2025
Q4
$353K Buy
1,078
+262
+32% +$83.1K 0.16% 67
2025
Q3
$230K Buy
816
+552
+209% +$160K 0.1% 73
2025
Q2
$73.7K Buy
264
+242
+1,100% +$68.6K 0.04% 88
2025
Q1
$6.85K Buy
+22
New +$6.5K ﹤0.01% 164

Other funds holding AMGN

Carolina Wealth Advisors's AMGN Position: Q2 2026 in Review

Carolina Wealth Advisors reduced its Amgen (AMGN) stake by 0.44% in Q2 2026, selling an estimated $19.5K and leaving 13,010 shares worth $4.71M. The position accounts for 1.85% of the portfolio, ranked #13.

Carolina Wealth Advisors first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Carolina Wealth Advisors held 13,010 shares of Amgen worth $4.71M as of Q2 2026.
  • Carolina Wealth Advisors sold 57 Amgen shares in Q2 2026, an estimated $19.5K.
  • Amgen made up 1.85% of Carolina Wealth Advisors's portfolio in Q2 2026, its #13 holding.
  • Carolina Wealth Advisors first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Carolina Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.